Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Metabolic Dysfunction-Associated Steatohepatitis (MASH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Global Clinical Trials Review, 2024
... Steatotic Liver Disease (MASLD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Report includes an overview of trial numbers and their average ... Read More
-
Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Herpes Zoster (Shingles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Idiopathic Hypersomnia (IH) - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Idiopathic Hypersomnia (IH) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Preclinical CRO Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global preclinical CRO market by segmenting the market based on ... Read More
-
Clinical Trial Support Services in the US - Industry Market Research Report
... and data, as well as preparing information for regulatory submission and data storage. Clinical trial support services include pharmacovigilance, site selection, cardiac safety monitoring, biostatistics and clinical data management. An increasing volume of clinical trials ... Read More
-
Cortical Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Cortical Stimulators pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Neurofibromatoses: Competitive Landscape
... countries covered in GlobalData’s epidemiology forecast. Currently, only one approved innovator drug, AstraZeneca‘s (Koselugo/Coselugo) selumetinib sulfate, is available on the market for the treatment of pediatric patients ages two years and older with NF type ... Read More
-
Global PD-1 and PD-L1 Inhibitors Market 2024-2028
... the pd-1 and pd-l1 inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Healthcare Cold Chain Logistics Market Size, Trends, Analysis, and Outlook By Product (Biopharmaceuticals, Vaccines, Clinical Trial Materials, Others), By Services (Storage, Transportation, Packaging, Others), By Storage Techniques (Electrical Refrigeration, Dry Ice, Gel Packs, Liquid Nitrogen, Others), By End-User (Biopharmaceutical companies, Hospitals and clinics, Research institutes, Others), by Country, Segment, and Companies, 2024-2032
... Others), By End-User (Biopharmaceutical companies, Hospitals and clinics, Research institutes, Others), by Country, Segment, and Companies, 2024-2032 Global Healthcare Cold Chain Logistics Market Size is valued at $18.3 Billion in 2024 and is forecast to ... Read More
-
Wegovy Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... reducing food consumption, and lowering calorie intake. Semaglutide has received approval from the US FDA for long-term weight management in adults who are obese or overweight with at least one weight-related condition, such as hypertension, ... Read More
-
Global Market for Contract Research Organization (CRO) Services
... of the clinical trial process, including a detailed description of all the phases and functional services CROs associated with clinical trials; and it details the major therapeutic areas covered by CROs and their broad service ... Read More
-
Medical Cannabis Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the medical cannabis market by segmenting the market based on species, molecule, end ... Read More
-
Esophageal Cancer: Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast. Chemotherapy forms the backbone of therapy in patients with advanced or metastatic EC. There are 22 innovator drugs marketed for EC across geographies. The EC pipeline has ... Read More
-
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape
... are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast. No disease-modifying treatment has proven to alter LGMD progression so far, and thus symptom management remains the mainstay of care. The LGMD pipeline holds ... Read More
-
North America Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)
... was valued at US$ 17,570.05 million in 2023 and is expected to reach US$ 29,104.42 million by 2031; it is estimated to register a CAGR of 6.5% from 2023 to 2031. Rising Prevalence of Chronic ... Read More
-
Middle East & Africa Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)
... clinical reference laboratory market was valued at US$ 2,168.12 million in 2023 and is expected to reach US$ 3,193.75 million by 2031; it is estimated to register a CAGR of 5.0% from 2023 to 2031. ... Read More
-
Europe Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)
... at US$ 13,431.17 million in 2023 and is expected to reach US$ 21,670.00 million by 2031; it is estimated to register a CAGR of 6.2% from 2023 to 2031. Increasing Number of Clinical Trials Drives ... Read More
-
Asia Pacific Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)
... was valued at US$ 9,814.13 million in 2023 and is expected to reach US$ 16,510.17 million by 2031; it is estimated to register a CAGR of 6.7% from 2023 to 2031. Strategic Initiatives with Reference ... Read More
-
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034
... the forecast period (2024–2034). This growth is primarily driven by rising diagnosed prevalent cases and the introduction of emerging therapies. According to DelveInsight's analysis, it is projected that approximately 41% of the Total Diagnosed Prevalent ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
... a full or partial extra copy of chromosome 21. This additional genetic material alters development, leading to the physical and intellectual characteristics associated with Down’s syndrome. The market size of Down’s syndrome in 2023 was ... Read More
-
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034
... United States accounted for 45% of the cases, while Japan and Germany represented 9% and 18% of the cases, respectively. DelveInsight’s epidemiology model projects that Parkinson’s disease cases in the US included nearly 695 thousand ... Read More
-
Global Clinical Research Digitization Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The Global Info Research report includes an overview of the development of the ... Read More
-
Gonorrhea (GN): Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast. Currently, the GN market contains many innovative therapies developed by big pharma giants. R&D efforts for GN are limited. Currently, 33 molecules are in the pipeline, with ... Read More
-
Pre-eclampsia - Early-stage Therapy - Pipeline Insight 2024
... of gestation and is characterized by high blood pressure, proteinuria, and sometimes organ damage such as kidney impairment, liver dysfunction, or neurological symptoms. Moreover, if left untreated or if it becomes severe, pre-eclampsia can result ... Read More
Research Assistance
